Topics
November/December 2016 | Special Focus: The Year In Review
Recapping the Past 12 Months
the staff of Retina Today
November/December 2015 | Special Focus: The Year In Review
In the Rearview: Highlights of Happenings From 2015
A brief look at significant events, innovative products, and other notable headlines from the past year.
From the staff of Retina Today
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations
Mogrify to Present Preclinical Data on Retinal Regeneration Therapy at FLORetina-ICOOR 2026
November 10, 2026
Imvionix Acquires US and Canadian Commercial Rights to Beovu from Novartis
City Therapeutics Doses First Participant in Phase 1 Trial of CITY-RBP4 for Stargardt Disease
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Supported by Zeiss
Free Print Subscription
Email Newsletter
Conference Calendar
